| Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid KK Matthay, JG Villablanca, RC Seeger, DO Stram, RE Harris, ... New England Journal of Medicine 341 (16), 1165-1173, 1999 | 2281 | 1999 |
| Determination of subcutaneous tumor size in athymic (nude) mice MM Tomayko, CP Reynolds Cancer chemotherapy and pharmacology 24, 148-154, 1989 | 2020 | 1989 |
| Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma AL Yu, AL Gilman, MF Ozkaynak, WB London, SG Kreissman, HX Chen, ... New England Journal of Medicine 363 (14), 1324-1334, 2010 | 1953 | 2010 |
| Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy MH Kang, CP Reynolds Clinical cancer research 15 (4), 1126-1132, 2009 | 1328 | 2009 |
| Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A … KK Matthay, CP Reynolds, RC Seeger, H Shimada, ES Adkins, ... Journal of clinical oncology 27 (7), 1007-1013, 2009 | 1003 | 2009 |
| Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma CJ Thiele, CP Reynolds, MA Israel Nature 313 (6001), 404-406, 1985 | 779 | 1985 |
| Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group WB London, RP Castleberry, KK Matthay, AT Look, RC Seeger, ... Journal of clinical oncology 23 (27), 6459-6465, 2005 | 697 | 2005 |
| Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma M Sausen, RJ Leary, S Jones, J Wu, CP Reynolds, X Liu, A Blackford, ... Nature genetics 45 (1), 12-17, 2013 | 533 | 2013 |
| The pediatric preclinical testing program: description of models and early testing results PJ Houghton, CL Morton, C Tucker, D Payne, E Favours, C Cole, ... Pediatric blood & cancer 49 (7), 928-940, 2007 | 509 | 2007 |
| Ceramide synthesis and metabolism as a target for cancer therapy CP Reynolds, BJ Maurer, RN Kolesnick Cancer letters 206 (2), 169-180, 2004 | 450 | 2004 |
| Retinoid therapy of high-risk neuroblastoma CP Reynolds, KK Matthay, JG Villablanca, BJ Maurer Cancer letters 197 (1-2), 185-192, 2003 | 397 | 2003 |
| Outcome after reduced chemotherapy for intermediate-risk neuroblastoma DL Baker, ML Schmidt, SL Cohn, JM Maris, WB London, A Buxton, ... New England Journal of Medicine 363 (14), 1313-1323, 2010 | 354 | 2010 |
| The majority of total nuclear-encoded non-ribosomal RNA in a human cell is' dark matter'un-annotated RNA P Kapranov, G St Laurent, T Raz, F Ozsolak, CP Reynolds, ... BMC biology 8, 1-15, 2010 | 333 | 2010 |
| Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines BJ Maurer, LS Metelitsa, RC Seeger, MC Cabot, CP Reynolds Journal of the National Cancer Institute 91 (13), 1138-1146, 1999 | 330 | 1999 |
| Antitumor activity of hu14. 18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study S Shusterman, WB London, SD Gillies, JA Hank, SD Voss, RC Seeger, ... Journal of Clinical Oncology 28 (33), 4969-4975, 2010 | 326 | 2010 |
| Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial SG Kreissman, RC Seeger, KK Matthay, WB London, R Sposto, SA Grupp, ... The lancet oncology 14 (10), 999-1008, 2013 | 303 | 2013 |
| Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines N Keshelava, JJ Zuo, P Chen, SN Waidyaratne, MC Luna, CJ Gomer, ... Cancer research 61 (16), 6185-6193, 2001 | 297 | 2001 |
| High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. N Hailat, DR Keim, RF Melhem, XX Zhu, C Eckerskorn, GM Brodeur, ... The Journal of clinical investigation 88 (1), 341-345, 1991 | 289 | 1991 |
| Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma TJ Moss, CP Reynolds, HN Sather, SG Romansky, GD Hammond, ... New England Journal of Medicine 324 (4), 219-226, 1991 | 285 | 1991 |
| Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641 DR Strother, WB London, ML Schmidt, GM Brodeur, H Shimada, ... Journal of clinical oncology 30 (15), 1842-1848, 2012 | 278 | 2012 |
John M MarisProfessor Pediatrics, Children's Hospital of Philadelphia and University of PennsylvaniaVerifisert e-postadresse på chop.edu
